Novo Nordisk Canada Inc.

Ontario – Toronto GTA – Mississauga

Corporation

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Corporation

active

Novo Nordisk is a focused healthcare company. With the broadest
diabetes product portfolio in the industry, including the most
advanced products within the area of insulin delivery systems,
Novo Nordisk is the world leader in diabetes care. In addition,
Novo Nordisk has a leading position within areas such as
coagulation disorders, growth disorders and hormone replacement
therapy. Novo Nordisk manufactures and markets pharmaceutical
products and services that make a significant difference to
patients, the medical profession and society.
Country of Ownership: Foreign
Year Established: 1993
Exporting: Yes
Primary Industry (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Primary Business Activity: Manufacturer / Processor / Producer
Total Sales ($CDN): $50,000,000 +
Number of Employees: 100

Services:
Biotechnology

Products:
Novolin, Niastase, Novolin pen, Novorapid, Gluconorm, Induo, Innovo, Flexpen, Novofine needles, Novopen junior, Vagifem, Novomix 30, Levemir

No associations

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian companies and directors. Rate them and share your experience with other people.

Rating

Novo Nordisk Canada Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Novo Nordisk Canada Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novo Nordisk Canada Inc. will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-COD-O-22609

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.